Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(E)-(S)-4-[(S)-4-methyl-2-((S)-3-methyl-2{(S)-2-[(5-methyl-isoxazole-3-carbonyl)-amino]-propionylamino}-butyrylamino)-pentanoylamino]-5-((S)-2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the molecular formula C30H46N6O8 and a molecular weight of approximately 618.7 g/mol[1][3][4]. It is listed in chemical databases such as PubChem and DrugBank under the identifier DB04710, but there is no evidence that it has been approved for clinical use or advanced beyond experimental status[1][3]. The structure contains an isoxazole moiety, multiple peptide-like amide bonds, and an ethyl ester functional group. No specific mechanism of action, biological target, or therapeutic indication has been described in public sources[1][3].
- Other names
- (E)-(S)-4-METHYL-2-( (S ) -3-METHYL - 2 { ( S ) - 2 - [ ( 5-METHYL - ISOXAZOLE - 3-CARBONYL ) - AMINO ] - PROPIONYLAMINO } - BUTYRYLAMINO ) - PENTANOYLAMINO ] –5– (( S ) – 2– OXO-PYRROLIDIN –3– YL) –PENT–2–ENOIC ACID ETHYL ESTER
Beyond the preview
Go deeper on (E)-(S)-4-[(S)-4-methyl-2-((S)-3-methyl-2{(S)-2-[(5-methyl-isoxazole-3-carbonyl)-amino]-propionylamino}-butyrylamino)-pentanoylamino]-5-((S)-2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (E)-(S)-4-[(S)-4-methyl-2-((S)-3-methyl-2{(S)-2-[(5-methyl-isoxazole-3-carbonyl)-amino]-propionylamino}-butyrylamino)-pentanoylamino]-5-((S)-2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester.